Search Results < Thoracic

201 results

News
Raise Your Voice About Your Metastatic Breast Cancer
Breast cancer is a common diagnosis for women of all races. But there are differences along racial lines when it comes to early detection, treatment, and survival rates.
Source: WEBMD
13 Jan 2023
News
HER2 Low Breast Cancer: New Clinical Entity or Testing Artifact
Should breast cancer patients with low but not negative tumor expression of HER2 be considered a distinct patient group that can be treated differently from patients with tumors that are HER2 negative or HER2 positive? That was the question posed during a session at the recent San Antonio Breast Cancer Symposium (SABCS) 2022.
Source: Medscape
5 Jan 2023
News
New Treatments Keeping Women Alive Longer Through Breast Cancer
Five percent of women diagnosed with breast cancer have metastatic disease, but survival rates are climbing. According to the Breast Cancer Research Foundation, the number of women living with metastatic breast cancer rose to 168,000 last year from 155,000 the year before. New breakthroughs keep women alive longer while researchers race to find the next therapy that will work.
Source: WINK
19 Dec 2022
News
‘This is About Saving Women’s Lives’: Find It Early Act Aims to Increase Breast Cancer Screenings
Congresswoman Rosa DeLauro announced the introduction of the Find It Early Act which, if passed, would require insurance companies to cover mammograms, breast ultrasounds, and MRIs to increase early cancer detection.
13 Dec 2022
News
Patient Selection for AstraZeneca, Daiichi Breast Cancer Drug Needs Improvement, Experts Say
The rush to use AstraZeneca and Daiichi-Sankyo’s drug Enhertu to treat certain types of breast cancer has far outpaced doctors’ ability to determine with certainty which patients might benefit, experts said this week at a meeting of breast cancer doctors.
Source: Financial Post
9 Dec 2022
News
SABCS Data Solidifies Enhertu as Preferred Second-, Third-Line HER2-Positive Breast Cancer Treatment
SAN ANTONIO – Two Phase II trials of Daiichi Sankyo and AstraZeneca's Enhertu
Source: Precision Oncology News
8 Dec 2022
News
Spatial and Single Cell Characterization of Breast Cancer Progression: Presenter Profile
Presentation is about methods for assessment of multiple molecular variables on a single piece of tissue to better understand breast cancer (or really any cancer) with respect to progression or response or resistance to specific therapies.
Source: SABCS Meeting News
7 Dec 2022
News
Panel to Examine the Ongoing Evolution of Antibody Drug Conjugates in the Treatment of Breast Cancer
Antibody drug conjugates (ADCs), which use a targeted monoclonal antibody to deliver a cytotoxic payload, are among the most effective breast cancer therapies yet developed. The first Food and Drug Administration approval of an ADC in breast cancer, ado-trastuzumab emtansine, better known as T-DM1, sparked development of numerous new and promising ADCs for breast cancer.
Source: SABCS Meeting News
7 Dec 2022
News
Trastuzumab Deruxtecan Generates OS Benefit Vs Capecitabine-based Regimens in Pretreated HER2+ Breast Cancer
Trastuzumab deruxtecan demonstrated a 34% reduction in the risk of death and a 13-month increase in overall survival compared with treatment of physician’s choice in patients with advanced HER2-positive unresectable and/or metastatic breast cancer who received prior treatment with trastuzumab emtansine.
Source: OncLive
7 Dec 2022
News
Plastic and Reconstructive Surgeon joins Smilow Cancer Hospital
Haripriya Ayyala, MD, has been named an Assistant Professor of Surgery (Plastic and Reconstructive Surgery) and cares for patients as part of the Center for Breast Cancer at Smilow Cancer Hospital and Yale Cancer Center.
21 Nov 2022
News
Smilow Cancer Hospital and Yale Police Team to Raise Breast Cancer Awareness
Members of Smilow Cancer Hospital and Yale Cancer Center spent time together on Friday, October 28 on the New Haven Green with members of the Yale Police Department – along with a special, pink-themed Yale Police SUV – to highlight Breast Cancer Awareness Month.
31 Oct 2022
News
Pembrolizumab Shows EFS Benefit in TNBC Without Complete Response
Lajos Pusztai, MD, DPhil, discusses key takeaways from analysis of the KEYNOTE-522 clinical trial of pembrolizumab plus chemotherapy in the neoadjuvant or adjuvant setting for patients with triple-negative breast cancer.
Source: Targeted Oncology
27 Oct 2022
News
Connecticut Woman Says Her Breast Cancer Didn’t Feel Like She Thought It Would
(WTNH) – October is Breast Cancer Awareness Month and each week in our Positively Pink series we are introducing survivors. One woman discovered her own breast cancer, but she says it didn’t feel like she thought it would.
Source: WTNH
26 Oct 2022
News
Contraceptive Use Declines After Breast Cancer Diagnosis
Contraceptive use declined significantly after treatment for early breast cancer, according to a prospective analysis of nearly 3000 premenopausal women.
Source: MedScape
21 Oct 2022
News
Glastonbury Breast Cancer Patient Raises Awareness and Funds for Yale Cancer Center
NEW HAVEN, Conn. (WTNH) — “I believe that this is a gift from God,” said 47-year-old Sandy Cassanelli of Glastonbury. News 8 first met the mom-of-two in October of 2018 at Dee’s One Smart Cookie, raising awareness and funds for her organization, Breast Friends Fund. And again in 2020, supporting the mission in the fresh air during the pandemic, spreading her message through group yoga at a farm. “I was put on this earth for this reason, to have this disease, and do what I do and show people faith, show people hope, love,” she said.
Source: WTNH
20 Oct 2022
News
Experts Say There's a Greater Need for Access to Care Among Those with Dense Breast Tissue
Detecting cancer is more difficult in women with dense breasts. Those women are more likely to be women of color, experts say.
Source: NBC CT
20 Oct 2022
News
Black Women Are Still More Likely to Die of Breast Cancer Than White Women — Here's What Experts Want You to Know
The American Cancer Society released new statistics about racial disparities in breast cancer mortality rate.
Source: SHAPE
17 Oct 2022
News
The Importance of HER2 Categorization for Metastatic Breast Cancer Treatment
Deconstructing a long-held diagnostic standard has expanded treatment options for over half of metastatic breast cancer patients.
Source: Washington Post
14 Oct 2022
News
More Than Mammograms: We Break Down the Different Types of Breast Cancer Screenings
Find out why a mammogram might not be enough. Every year in the United States, about 264,000 cases of breast cancer are diagnosed in women and about 2,400 are found in men, according to the CDC. This year, Katie was one of them. On average, a woman has a roughly one in eight chance of developing breast cancer in her lifetime. In stark black and white, these sound like pretty alarming statistics — but the numbers don’t tell the whole story.
Source: Katie Couric Media
14 Oct 2022
News
Advancing Care - October 2022
That ache in your belly: Is it a hernia? Don’t get blindsided by dry eye syndrome Screening is key to detect breast cancer Schedule your mammogram online Laboratory services are open Find a Doc at L+M or WHM Billing questions?
Source: YNHH Lawrence Memorial Hospital
13 Oct 2022